The 3rd annual Immuno-Oncology 360° event takes place February 1-3, 2017 in NYC. Lead advisors, Dr Axel Hoos (GSK) and Dr James Gulley (NCI) co-present a program that provides a 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated. In this brief radio blog post, get a five minute overview on what to expect at IO360 2017! For more information on the entire event and speaking faculty, visit, www.theconferenceforum.org

Immuno-Oncology 360 Conference in 5 Minutes: What to Expect?

Share

Embed